Council of Scientific & Industrial Research (CSIR) Director General Shekhar C Mande said that it is very difficult to compare the efficacy of hydroxychloroquine and remdesivir as of now. “Comparison between hydroxychloroquine & remdesivir is not right because we do not know the efficacy of both of them till now. Which one is better can only be ascertained after trials,” said Dr Mande.
